Search

Search Constraints

You searched for: Is Part Of Prostate. Volume 79:Issue 12(2019)

Search Results

1. A novel androgen‐reduced prostate‐specific lncRNA, PSLNR, inhibits prostate‐cancer progression in part by regulating the p53‐dependent pathway. Issue 12 (3rd July 2019)

4. An exploratory retrospective multicenter study of prognostic factors in mCRPC patients undergoing enzalutamide treatment: Focus on early PSA decline and kinetics at time of progression. Issue 12 (23rd July 2019)

5. Concentration‐dependent effects of dutasteride on prostate‐specific membrane antigen (PSMA) expression and uptake of 177Lu‐PSMA‐617 in LNCaP cells. Issue 12 (24th June 2019)

9. MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL. Issue 12 (3rd July 2019)